Keratinocyte growth factor active polypeptide and application thereof
A technology for growth factor activity and keratinocytes, which is applied in the field of keratinocyte growth factor active polypeptides, and can solve problems such as no active polypeptide gels
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2022-04-08
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a keratinocyte growth factor active polypeptide and an application thereof, belonging to the technical field of keratinocyte growth factor active polypeptides. Background technique
[0002] Wound healing is a complex process of repairing tissue defects. Abnormal wound healing will lead to chronic refractory wounds, which is a clinical problem that needs to be solved urgently. Topical application of growth factors helps to promote wound healing, but currently used growth factor products are expensive, have a short biological half-life, poor stability, are easily affected by the local environment of the wound, and are difficult to achieve the expected therapeutic effect, which limits their wide application.
[0003] At present, the research and application of peptides have reached an unprecedented level of prosperity. Compared with natural protein, it has the advantages of smaller molecular weight, single function, less side eff...
Examples
Embodiment 1
[0032] Embodiment 1: Screening of KGF active polypeptide sequence
[0033] Coat the 96-well plate with human KGF monoclonal antibody, add phage random heptapeptide library (purchased from NEB Company, USA) and incubate overnight at 4°C, wash the plate 10 times with TBST, and wash the plate with elution buffer (0.2mol / L Glycine-HCl , pH value of 2.2, 0.1% BSA) to elute the bound phage, neutralization buffer (1mol / L Tris-HCl, pH value of 9.1) quickly neutralizes the eluate.
[0034] E.coli ER2738 host bacteria were used to amplify the eluate for the next round of screening. In the same way, three rounds of screening were performed on the eluate from each round. Titer determination was carried out on the eluate of the fourth round, phage coeruleus was randomly selected, amplified, and adjusted to 2.0×10 13 pfu / mL.
[0035] The ELISA method and the human KGF immunoassay kit (purchased from R&D Company, USA) were used to detect the binding ability of the monoclonal phage accordi...
Embodiment 2
[0047] Embodiment 2: the synthesis of KGF active polypeptide
[0048] The KGF polypeptide sequence obtained by screening in Example 1 was sent to Wuhan Minghao Biotechnology Co., Ltd. for the synthesis of KGF active short peptide, purified to 98% purity, and then the C-terminus of the polypeptide was amidated and blocked to enhance the stability of the active polypeptide ; Rhodamine laser dye labeling of the N-terminus of the polypeptide is used to identify the affinity of the active polypeptide to epidermal cells and to detect whether it can be combined with epidermal cells. Prepared into freeze-dried powder and stored at -20°C.
Embodiment 3
[0049] Embodiment 3: In vivo and in vitro experiments of KGF active polypeptide
[0050] The cultured epidermal cells were intervened with KGF active peptides, because the KGF active peptides were labeled with rhodamine laser dye, and the results of immunofluorescence detection showed that the KGF active peptides could combine with the specific receptor KGFR on the epidermal cells.
[0051] The KGF active polypeptide was further co-cultured with human epidermal cells for in vitro experiments, and the effect of the KGF active polypeptide on the proliferation of epidermal cells was detected by the CCK-8 method. The results showed that the KGF active polypeptide could promote the proliferation of epidermal cells in a concentration-dependent manner. RT-PCR and Western-blot were used to detect the expression level of the specific receptor KGFR on the epidermal cells, and the results showed that the KGF active polypeptide could promote the expression of KGFR on the epidermal cells. ...